Skip to main content
  • Management
      |Management
    • Compensation
    • Economics
    • Leadership
    • Legal News
    • Mergers & Acquisitions
    • Patient Care
    • Policy & Regulations
    • Practice Management
    • Professional Associations
    • Quality
    • Staffing
  • Imaging
      |Imaging
    • CT
    • MRI
    • Nuclear Medicine
    • Ultrasound
    • Women's Imaging
    • X-ray
  • Technology
      |Technology
    • Artificial Intelligence
    • Enterprise Imaging
    • Imaging Informatics
    • Informatics
    • PACS
  • Videos
  • Conferences
      |Conferences
    • ACR
    • AHRA
    • ARRS
    • ASRT
    • RBMA
    • RSNA
    • SBI
    • SCCT
    • SIIM
    • SIR
    • SNMMI
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025
    • Class of 2024

Search form

Home

News You Need to Know Today
Whole-body PET/CT vs. nose cancer metastases | Superfluous MSK reads
Saturday, March 16, 2019
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Whole-body PET/CT ferrets out metastases traveling from sinonasal cancers

Whole-body PET/CT with the standard radiotracer 18F-FDG is a dependable screening tool for catching many metastases, distant as well as regional lymphatic, according to researchers at the University of Minnesota.

READ MORE >
Nose
Share on Twitter Share on Facebook Share on Linkedin

Whole-body PET/CT ferrets out metastases traveling from sinonasal cancers

Share on Twitter Share on Facebook Share on Linkedin
Nose
Whole-body PET/CT with the standard radiotracer 18F-FDG is a dependable screening tool for catching many metastases, distant as well as regional lymphatic, according to researchers at the University of Minnesota.
READ MORE >

Radiologist reads of pediatric arm fractures found superfluous, costly

Once a child’s broken arm is on the mend, little to nothing is gained by having follow-up x-rays read by both radiologists and orthopedic surgeons, according to a study conducted at Case Western Reserve University and published online March 6 in the Journal of Pediatric Orthopaedics.

READ MORE >
Slip and Fall
Share on Twitter Share on Facebook Share on Linkedin

Radiologist reads of pediatric arm fractures found superfluous, costly

Share on Twitter Share on Facebook Share on Linkedin
Slip and Fall
Once a child’s broken arm is on the mend, little to nothing is gained by having follow-up x-rays read by both radiologists and orthopedic surgeons, according to a study conducted at Case Western Reserve University and published online March 6 in the Journal of Pediatric Orthopaedics.
READ MORE >

Abdominal MRI patients move less when holding breath at end of exhale

To cut respiratory motion artifacts on liver MRI, have patients hold their breath at the end of an exhale rather at the end of an inhale. That’s the recommendation of Stanford researchers after testing and comparing the two techniques, and it holds for unenhanced and contrast-enhanced scans.

READ MORE >
Holding Breath
Share on Twitter Share on Facebook Share on Linkedin

Abdominal MRI patients move less when holding breath at end of exhale

Share on Twitter Share on Facebook Share on Linkedin
Holding Breath
To cut respiratory motion artifacts on liver MRI, have patients hold their breath at the end of an exhale rather at the end of an inhale. That’s the recommendation of Stanford researchers after testing and comparing the two techniques, and it holds for unenhanced and contrast-enhanced scans.
READ MORE >

NCI director Norman Sharpless named new FDA acting commissioner

Norman E. Sharpless, MD, director of the National Cancer Institute (NCI) since October 2017, has been announced as the new acting commissioner of the FDA. Sharpless replaces Scott Gottlieb, MD, who unexpectedly resigned from the position on March 5.

READ MORE >
Norman E. Sharpless, MD
Share on Twitter Share on Facebook Share on Linkedin

NCI director Norman Sharpless named new FDA acting commissioner

Share on Twitter Share on Facebook Share on Linkedin
Norman E. Sharpless, MD
Norman E. Sharpless, MD, director of the National Cancer Institute (NCI) since October 2017, has been announced as the new acting commissioner of the FDA. Sharpless replaces Scott Gottlieb, MD, who unexpectedly resigned from the position on March 5.
READ MORE >

Featured Articles

No gadolinium, no problem: Specialists can monitor MS patients with unenhanced MRI

Gadolinium-based contrast agents (GBCAs) are typically administered during follow-up imaging of multiple sclerosis (MS) patients. According to new research published in Radiology, however, unenhanced MRI scans are sufficient.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

No gadolinium, no problem: Specialists can monitor MS patients with unenhanced MRI

Share on Twitter Share on Facebook Share on Linkedin
Gadolinium-based contrast agents (GBCAs) are typically administered during follow-up imaging of multiple sclerosis (MS) patients. According to new research published in Radiology, however, unenhanced MRI scans are sufficient.
READ MORE >

Tracking follow-up imaging adherence rates can lead to better patient care

Follow-up imaging adherence rates vary based on a number of factors, according to new research published in the American Journal of Roentgenology. The authors noted that closely monitoring such patterns can help providers engage patients and minimize risk.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Tracking follow-up imaging adherence rates can lead to better patient care

Share on Twitter Share on Facebook Share on Linkedin
Follow-up imaging adherence rates vary based on a number of factors, according to new research published in the American Journal of Roentgenology. The authors noted that closely monitoring such patterns can help providers engage patients and minimize risk.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Best of the Week: MRI links anxiety to brain changes | AI equals rads at prostate cancer detection | 4 deaths prompt US recall
Senate bill would slash radiology spending | MRI links ultraprocessed foods to brain injury | New imaging clinic chain launches
How departments are reducing wait times | Program increases exposure to radiology careers | Gaps in radiation safety knowledge
A warning about BI-RADS | 3-step buyer's guide for radiology AI | IR procedure reduces steroid reliance for KOA | Rad turnover
Radiologists worry of ripple effect after false claims | AI matches rads at prostate cancer detection | Rad Partners scores win
GE HealthCare acquiring radiopharma firm | RP seeks to expand teleradiology services | Telix and ITM merge in $1.65B deal | More
Siemens Healthineers ends general ultrasound sales | More liver cancer patients turning to IR treatments | Anxiety on MRI
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup